-
Indo-MIM
757.50 757.50(%) -
Bajaj Finserv
1,891.35 1,598.15(%) -
Bajaj Finance
1,067.05 1,102.45(%) -
ICICI Bank
1,423.00 1,187.55(%) -
HDFC Bank
758.00 1,020.35(%) -
Adani Green
1,350.10 767.00(%) -
Reliance Industries
1,298.00 1,611.20(%) -
DLF
652.05 489.30(%) -
TBO Tek
1,473.20 1,005.50(%) -
Eicher Motors
7,929.00 8,232.80(%) -
Kalyan Jewellers
649.00 649.00(%) -
M & M
3,325.00 3,840.00(%) -
TVS Motor Co.
4,219.00 4,219.00(%) -
Infosys
1,187.00 1,727.85(%) -
Coforge
1,763.70 1,988.90(%) -
Jubilant Food.
433.80 408.50(%) -
Waaree Energies
2,563.00 2,402.00(%) -
Cholaman.Inv.&Fn
1,758.65 1,299.80(%) -
Redington
338.20 338.20(%) -
SBI
1,030.00 1,234.80(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aurobindo Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4666.0
- ISIN : INE406A01037
-
Today’s Low
1,566.20 -
Today’s High
1,607.50
-
Open
1,590.00 -
Perv Close
1,590.70 -
52W Low
1,016.10 -
52W High
1,636.80
Key Indicators
-
P/E(TTM)
37.68
-
Mar.Cap (₹Cr.)
91,551.76
-
Div & Yield %
0.25
-
Book Value(₹)
391.14
-
Debt-Equity Ratio
-0.91
-
AGM Date
30-Jul-2026
-
EPS
41.81
-
P/E Ratio
37.68
Financials Ratios
-
Debt-Equity Ratio
0.21
-
Mar.Cap (₹Cr.)
91,551.76
-
RONW (%)
11.18
-
ROCE (%)
13.51
Score Board
-
Equity (₹ in Cr.)
58.08
-
BV (₹)
391.10
-
Sales( ₹ in Cr.)
11,055.39
-
NP (in Cr.)
2,428.07
-
NP Var(%)
39.0
-
Div%
400.0
-
CPS (₹)
46.70
-
EPS (₹)
41.80
-
Traded Value (₹ in Lakhs)
91,502.39
-
52 Week High
1,636.80
-
52 Week Low
1,016.10
-
Price BSE
1575.0
-
Price NSE
1,576.00
-
Market Capital( in Cr.)
91,502.39
-
P/C Ratio
33.70
-
P/E Ratio
37.70
-
Price Vs.BV
41.80
-
28-Jul-2026( 10:36)
Corporate News - Aurob... - Aurobindo Pharma will hold a m...
-
22-Jul-2026( 11:27)
Hot Pursuit - Aurob... - The approval follows a GMP ins...
-
10-Jul-2026( 06:38)
Corporate News - Aurob... - Aurobindo Pharma announced tha...
-
02-Jul-2026( 01:46)
Corporate News - Aurob... - Aurobindo Pharma has completed...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 10,933.30 | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 | 13,370.77 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10,933.30 | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 | 13,370.77 |
| Other Income | 328.12 | 670.10 | 443.92 | 670.99 | 589.86 | 388.79 |
| Stock Adjustments | 67.66 | 116.23 | 263.95 | -45.51 | -2.99 | 238.67 |
| Total Income | 11,329.08 | 11,431.97 | 9,164.87 | 11,912.62 | 16,410.55 | 13,998.23 |
| EXPENDITURE : | ||||||
| Raw Materials | 5,675.34 | 5,964.48 | 4,755.95 | 5,800.74 | 7,241.83 | 6,819.85 |
| Power and Fuel Cost | 185.59 | 191.58 | 167.86 | 477.99 | 512.34 | 526.31 |
| Employee Cost | 1,063.07 | 980.56 | 890.53 | 1,600.04 | 1,735.42 | 1,577.14 |
| Other Manufacturing Expenses | 426.63 | 414.51 | 328.42 | 705.68 | 925.86 | 814.44 |
| Selling and Administration Expenses | 960.27 | 822.21 | 939.38 | 1,009.36 | 1,069.84 | 938.36 |
| Miscellaneous Expenses | 132.49 | 164.49 | 148.96 | 249.13 | 215.57 | 235.47 |
| Employee Benefit Expenses | 1,063.07 | 980.56 | 890.53 | 1,600.04 | 1,735.42 | 1,577.14 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 8,443.39 | 8,537.83 | 7,231.10 | 9,842.94 | 11,700.86 | 10,911.57 |
| Operating Profit | 2,885.69 | 2,894.14 | 1,933.77 | 2,069.68 | 4,709.69 | 3,086.66 |
| Interest | 230.04 | 182.60 | 74.58 | 16.94 | 28.68 | 243.28 |
| Gross Profit | 2,655.65 | 2,711.54 | 1,859.19 | 2,052.74 | 4,681.01 | 2,843.38 |
| Depreciation | 297.20 | 254.58 | 243.26 | 415.26 | 488.00 | 473.33 |
| Profit Before Tax | 2,358.45 | 2,456.96 | 1,615.93 | 1,637.48 | 4,193.01 | 2,370.05 |
| Current Tax | 627.37 | 598.08 | 412.16 | 379.70 | 1,043.34 | 492.28 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -15.71 | -95.26 | -23.34 | -196.93 | 36.76 | 0.89 |
| Reported Net Profit | 1,746.79 | 1,954.14 | 1,227.11 | 1,454.71 | 3,112.91 | 1,876.88 |
| Extraordinary Items | 5.48 | 3.28 | 9.94 | -81.27 | -0.13 | -1.90 |
| Adjusted Net Profit | 1,741.31 | 1,950.86 | 1,217.17 | 1,535.98 | 3,113.04 | 1,878.78 |
| Adjustment below Net Profit | -5.26 | -1.69 | 8.28 | 1.69 | -6.42 | -44.88 |
| P & L Balance brought forward | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 | 11,799.30 | 10,143.08 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 263.66 | 439.45 | 263.67 | 234.38 | 175.78 |
| P & L Balance carried down | 20,090.40 | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 | 11,799.30 |
| Dividend | 0.00 | 263.66 | 439.45 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 450.00 | 750.00 | 900.00 | 400.00 | 300.00 |
| Dividend Per Share(Rs) | 0.00 | 4.50 | 7.50 | 9.00 | 4.00 | 3.00 |
| Earnings Per Share-Unit Curr | 30.08 | 33.35 | 20.94 | 24.83 | 53.13 | 32.03 |
| Earnings Per Share(Adj)-Unit Curr | 30.08 | 33.35 | 20.94 | 24.83 | 53.13 | 32.03 |
| Book Value | 353.55 | 336.62 | 307.80 | 292.15 | 271.80 | 222.78 |
| Book Value(Adj)-Unit Curr | 353.55 | 336.62 | 307.80 | 292.15 | 271.80 | 222.78 |
